Presently, CD138 has the highest clinical importance in multiple myeloma (MM) as it is highly expressed in differentiated plasma cells and MM cells and is therefore used as a marker for the identification of MM cells [23]. This evidence concerns the gene SDC1 and plasma cell myeloma.